Gildea Edward J 4
4 · MARIMED INC. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Marimed (MRMD) Director Edward J. Gildea Exercises 75,000 RSUs
What Happened
- Edward J. Gildea, a director of Marimed Inc. (MRMD), converted/exercised 75,000 restricted stock units (RSUs) into 75,000 shares of common stock on June 12, 2026. The conversion shows an acquisition of 75,000 shares at $0.00 and a corresponding disposition entry for 75,000 RSU derivatives at $0.00.
Key Details
- Transaction date: 2026-06-12; Transaction code: M (exercise/conversion of derivative)
- Price: $0.00 per share; Shares acquired: 75,000 common shares
- Disposition: 75,000 RSU derivatives terminated/converted (reported as $0)
- Shares owned after transaction: Not specified in the filing
- Footnotes: (F1) RSUs convert to common stock on a one-for-one basis. (F2) These RSUs were granted on June 12, 2025 and there are no RSUs remaining under that grant per the award terms.
- Filing timeliness: Reporting period and filing date are the same (no late filing indicated)
Context
- This was a conversion of previously granted RSUs into common stock (an award vesting/settlement), not an open-market purchase or sale of existing shares. Such conversions often reflect vesting or settlement of compensation awards rather than a deliberate buy/sell decision by the insider.
Insider Transaction Report
Form 4
MARIMED INC.MRMD
Gildea Edward J
Director
Transactions
- Exercise/Conversion
Common stock
[F1]2026-06-12+75,000→ 980,208 total - Exercise/Conversion
Restricted Stock Units (RSU)
[F1][F2]2026-06-12−75,000→ 0 total→ Common Stock, par value $.001 per share (75,000 underlying)
Footnotes (2)
- [F1]RSUs convert to shares of common stock on a one-for-one basis.
- [F2]The RSUs were granted on June 12, 2025; there are no RSUs remaining under this grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person.
Signature
/s/ Edward Gildea|2026-06-12